Factsheet
As of 31 Mar 2025
SNPS
-
Consumer Products
/
Personal Products & Pharmaceuticals
CG Report :
-
SET ESG Ratings :
-
Business Type
Manufacturing and distribution of standardized herbal extracts and offering product development and manufacturing of health, beauty and hygiene products under customer brands (Original Design Manufacturer: ODM), and under brand of the Company's group (Original Brand Manufacturer: OBM)
405.00
2,085.75
1,706.83
122.09
13.98
5.15
6.45 /
3.90
25.72
2.41
Company Profile
700/364 Moo 6, Nongmaidang Chonburi 20000
0-3845-8698
0-3845-8697
FINANSIA SYRUS SECURITIES PUBLIC COMPANY LIMITED
29/09/1999
29 Nov 2024
4.20 @Par Value
1.00
Baht
1.00
Baht
Old -
: New - @
-
Shareholders
As of -
6,147 (as of 26 Nov 2024)
25.63% (as of 26 Nov 2024)
-% (as of 31 Mar 2025)
49.00% (as of 31 Mar 2025)
-
-
1.15% (as of 31 Mar 2025)
Board of Directors / Management
5 Yr Price Performance (Adjusted Price)
Change
Price Performance (Adjusted Price)
Statistics
Accumulated: Turnover Ratio, Value Trade/Day
Rate of Return
Dividend
Latest News
Auditor (Effective Until 31 Dec 2025)
Mr. MONGKOL SOMPHOL (DELOITTE TOUCHE TOHMATSU JAIYOS AUDIT CO., LTD.)Ms. PORAKOCH JONGKOLSIRI (DELOITTE TOUCHE TOHMATSU JAIYOS AUDIT CO., LTD.)Mr. WEE SUJARIT (DELOITTE TOUCHE TOHMATSU JAIYOS AUDIT CO., LTD.)MR. WONLOP VILAIVARAVIT (DELOITTE TOUCHE TOHMATSU JAIYOS AUDIT CO., LTD.)
Unqualified opinion
31 Dec
Financial Statements Submission Information
Financial Data
Statement of Financial Position Unit: M.Baht
Statement of Comprehensive Income Unit: M.Baht
Statement of Cash Flow Unit: M.Baht
Ratios Annualized : ROE,
ROA
Growth Rate (%)
Cash Cycle Annualized
Capital Movement (Last 3 Year)
Information only PP, PO, XR and XD
Trading Sign (Latest)
- Calculated from adjusted price
- Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
- The information is quarterly updated within 7 business days after the new financial statement is submitted
- Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.